K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Matthew E. Falagas
also known as Aoki, Falagas, M.E., M E Falagas
European University Cyprus · Boston University · Tufts University · Boston Medical Center
About this author
Works
972
Cited by
67,320
h-index
125
i10
529
ORCID ↗
Top papers
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
Anna-Pelagia Magiorakos, Arjun Srinivasan, Roberta B. Carey, et al.
·
2011
·
Clinical Microbiology and Infection
↗ 13,747
Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses
Matthew E. Falagas, Eleni Pitsouni, George Malietzis, et al.
·
2007
·
The FASEB Journal
↗ 4,731
Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
Γεώργιος Παππάς, Νίκος Ρούσσος, Matthew E. Falagas
·
2009
·
International Journal for Parasitology
↗ 1,157
Obesity and infection
Matthew E. Falagas, Maria Kompoti
·
2006
·
The Lancet Infectious Diseases
↗ 809
Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review
Petros I. Rafailidis, Eleni G. Mourtzoukou, Ioannis Varbobitis, et al.
·
2008
·
Virology Journal
↗ 638
OA
Fosfomycin
Matthew E. Falagas, Evridiki K. Vouloumanou, George Samonis, et al.
·
2016
·
Clinical Microbiology Reviews
↗ 592
OA
Comparison of SCImago journal rank indicator with journal impact factor
Matthew E. Falagas, Vasileios Kouranos, Ricardo Arencibia Jorge, et al.
·
2008
·
The FASEB Journal
↗ 545
Deaths Attributable to Carbapenem-Resistant<i>Enterobacteriaceae</i>Infections
Matthew E. Falagas, Giannoula S. Tansarli, Drosos E. Karageorgopoulos, et al.
·
2014
·
Emerging infectious diseases
↗ 503
OA
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
Matthew E. Falagas, Antonia C. Kastoris, Anastasios Kapaskelis, et al.
·
2009
·
The Lancet Infectious Diseases
↗ 482
Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis
Konstantinos A. Polyzos, Athanasios A. Konstantelias, Matthew E. Falagas
·
2015
·
EP Europace
↗ 480
OA
Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations
Javier Ariza, Mile Bosilkovski, Antonio Cascio, et al.
·
2007
·
PLoS Medicine
↗ 448
OA
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
Drosos E. Karageorgopoulos, Matthew E. Falagas
·
2008
·
The Lancet Infectious Diseases
↗ 447